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Abstract 
The hepatoprotective activity of crude extract of artemisia scoparia (aerial parts) was investigated
against experimentally produced hepatic damage using carbon tetrachloride (CCI4) as a model
hepatotoxin. CCl4 at the dose of 1.5 mI/kg, produced liver damage in rats as manifested by the rise in
serum levels of AST and ALT to 395±110 and 258±61 lU/I (mean ±SEM; n=10) respectively, compared
to control values of 106± 15 and 26±04. Pretreatment of rats with plant extract (150 mg/kg)
significantly lowered (P<0.01), the respective serum GOT and GPT levels to 93±05 and 27±03 IU/I,
indicating hepatoprotective action. Pentobarbital sodium (75 mg/kg)-induced sleeping time in mice was
found to be 140.8± 1.5 mm (n=10) which was similar (P>0.05) to that obtained in the group of animals
preheated with the plant extract (1 39.9±1.8 min). CCl4 treatment extended the pentobarbital sleeping
time to 212.2± 19.1 mm and pretreatment of animals with plant extract reversed the CCl4-induced
prolongation in pentobarbital sleeping time to 143.9±5.5 min (p<0.001) which further confirms the
protective action of the plant extract against CCl4-induced liver damage. These data indicate that the
plant artemisia scoparia is hepatoprotective and validate the folkioric use of this plant in liver damage
(JPMA 44:65, 1994).
Introduction 
Carbon tetrachloride (CCI4), a potent hepatotoxin, has been used extensively as a cleansing agent, fire
extinguisher, grain fumigant, vermifuge, solvent and as an intermediate in chlorofluorocarbon
synthesis. Its toxicity usually follows inhalation of the vapours in a poorly ventilated environment,
Ingestion of contaminated food (especially grains) and ground water1. Single exposure can rapidly lead
to severe centrizonal necrosis and steatosis2, whereas chronic or intermittent exposure may cause
cirrhosis3 and even hepatic malignancy4. In modem therapeutics, hepatic damage is regarded as a sort
of medical emergency because in the absence of specific therapy one has to be contented upon
conservative treatment. On the other hand, traditional healers claim certain valuable recipes based on
plants constituents showing preventive as well as curative potential. One such example, is artemisia
scoparia thunb. (Family: compositae; local name: Dona Than), having a folkloric reputation for its
usefulness in the treatment of jaundice and other liver disorders5. More recently, we have reported that
the crude extract of artemisia scoparia afforded protection against acetaminophen-induced
hepatotoxicity in rats6. In the present investigation, we have tested this plant extract against carbon
tetrachloride (CCI4)-induced liver injury to assess whether it also affords protection against a
commonly encountered environmental hepatotoxin with a different mode of hepatocellular damage7.
This can also be a step forward to help elucidate the possible mechanism of its hepatoprotective action.
Plant material:
Whole artemisia scoparia plants were collected during the month of April, 1991 from the rural area
around Thatta District in the province of Sindh, Pakistan and authenticated with the help of a botanist at
the University of Karachi. The plant material was shade dried, powdered and maceratect in 80%
aqueous-methanol (BDH Ltd., Poole, England) for 1 week with occasional shaking. The extract was
filtered and concentrated to dark greenish brown residue under reduced pressure on a rotary evaporator.
Pharmacological materials and animals:
CCl4, ketamine hydrochloride and pentobarbital sodium were obtained from Sigma Chemicals
Company, St. Louis, Mo, USA and olive oil (P. Sasso e Figili, Oneglia, Italy) was purchased from local
market. Swiss male mice (20-25g) and male albino Wistar rats (200-250g) housed at the animal house
of The Aga Khan University, were used for this study. The animals were housed in air conditioned
quarters and had free access to tap water and food.
Induction of hepatic Injury:
Hepatic injurywas produced by oral administration of 1.5 ml/kg CCl4 diluted upto 20% by olive oil and
the animals in the control group received an equal volume of olive oil.
Multiple dose treatment in rats:
Rats were divided into three groups of 10 animals each. Group 1 served as vehicle control and received
normal saline (3 ml/kg) and olive oil (7.5 nd/kg) orally. Group 2 served as toxic control and was given
4 doses of normal saline at 12 hours intervals and CCl4 was then administered orally 1 hour post-
treatment of the last dose. Group 3 was treated similar to group 2 except that plant extract (150 mg/kg)
was administered instead of saline. Animals were anaesthetized with ketamine (100 mg/kg, i.m.) 24
hours after the last treatment and blood (3 ml) was collected by cardiac puncture using sterile
disposable syringes. Serum was separated by centrifugation (3000 rpm, for 15 mAn) and serum
glutamate oxaloacetate transaminase (AST) and glutamate pyruvate transaminase MT were estimated
on the same day spectrophotometrically using Merck diagnostic kits.
Modification of pentobarbital-induced sleeping time:
The direct effect of plant extract on pentobarbital induced sleeping time and effect of plant extract on
CCI4-induced prolongation of pentobarbital sleeping time was studied in mice by using method
described by Montila and colleagues8, as shown in Table. To test the direct effect of plant extract on
pentobarbital- induced sleeping time, animals were divided into two groups of 10 animals each. Group
1 receive. Direct effect of artemisia scoparia on pentobarbital sleeping time as well as on CCl4-induced
prolongation of pentobarbital sleeping time im mice normal saline (3 mI/kg) while group 2 was given
plant extract (150 mg/kg) as a single oral dose and pentobarbital(75 mg/kg, i.p.) was then administered
after 1 hour to both the groups. To assess the effect of plant extract on CCL-induced prolongation of
pentobarbital sleeping time, 2 more groups were added to the study and were treated as follows: Group
3 received 4 doses of normal saline orally at 12 hrs intervals and CCLi was administered as a bolus
dose (1.5 ml/kg) 1 hr post-treatment of the last dose o. saline followed after 24 hrs by pentobarbital (75
mg/kg, i.p.). Animals in group 4 were treated similarly to group 3 except that plant extract (150 mg/kg)
was substituted for normal saline.
Statistical analysis:
The results are expressed as Mean S.E.M. and all statistical comparisons were made by means of
Student’s t-test and P <0.05 was regarded as a significant.
Results 
Effect of plant extract on CCl4-induced toxicity:
Control (saline + vehicle) serum values of GOT and GPT in rats were found to be 106±15 and 26 04
IU/L resspectively (Figure 1),
while a toxic dose of CCl4 (1.5 ml/kg) raised significantly (P< 0.01), the respective serum enzyme
values to 395± 110 and 258±61 IU/L. Group 3 was pretreated with plant extract (150 mg/kg, orally,
twice daily for 2 days) to determine its effect on CCl4-induced rise in serum enzymes. The serum
values in pretreated group were found to be 93±05 (GOT) and 27±03 IU/L (GPT), which are
significantly lower (Pc 0.01) than the values of toxic control and close to normal values (P> 0.05).
Effect of plant extract on pentobarbital-induced sleep:
Effect of plant extract on pentobarbital sleeping time as well as on CCI4-induced prolongation of pen
tobarbital sleeping time was studied in mice and the results are shown in Table.
Pentobarbital at a dose of 75mg/kg, i.p., caused sleep in mice for a period of 140.8±1.5 min
(Mean±S.E.M., n= 10). Pentobarbital sleeping time in the group of animals pretreated with plant
extract was found to be 139.9± 1.8 min which is similar to that in the control group (P>0.05). Whereas
pretreatment of animals with CCl4, prolonged the pentobarbital sleeping time to 212.2±19.1 min, the
value that is significantly higher (P <0.001) than that of control (Table). However, prior treatment of
animals with the plant extract returned this CCl4-induced prolongation of pentobarbital sleeping time
to 143.9±5.5 min, which is close to the control sleeping time (P >0.05). 
Discussion 
The crude extract of artemisia scoparia showed heaptoprotection against CCl4-induced liver injury. The
plant extract inhibited a CCl4-induced rise in serum AST and ALT in rats. Similarly, prevention pf
CCl4-induced prolongation of pentobarbital sleeping time was observed in a group of mice pre-treated
with the plant extract. Liver injury induced by CCl4 is a commonly used model for the screening of
hepatoprotective drugs9. The rise in serum levels of AST and ALT has been attributed to the damaged
structural integrity of the liver10 because these are cytoplasmic in location and are released into
circulation after cellular damage11. CCl4 is metabolized by a specific isozyme of cytochrome P-450
(IIE1) to variety of chemically reactive free radical species12. The free radical mediated toxic
manifestations can effectively be minimized by cytochrome P-450 inhibitors14, GSH precursors15, free
radical scavangers16, antioxidants17, sulfhydryl agents18 and Ca+ + channel blockers19,20. The crude
extract of artemisia scoparia plant used in this study seems to preserve the structural integrity of the
hepatocellular membrane. This was evident from the significant reduction in the CC14-induced rise in
serum AST and ALT levels in rats. To see whether the plant extract has inhibitory effect on hepatic
microsomal drug metabolizing enzymes (MDME), it was administered with pentobarbital to mice and
possible change in the duration of sleep was recorded. The duration of pentobarbital-induced sleep in
intact animal is considered as a reliable index for the activity of hepatic MDME21. Pentobarbital is
metabolized by the hepatic MDME to inactive metabolites and a drug with inhibitory effect on MDME
is expected to prolong pentobarbital sleep time. The fact that the plant extract did not modify
pentobarbital sleeping time (P> 0.05) suggests that it is devoid of inhibitory effect on hepatic MDME
such as cytochrome p-450. The damage conferred by CCl4 to hepatocytes as well as hepatic MDME
causes loss of drug metabolizing capacity of the liver, resulting in prolongation of pentobarbital-
induced sleeping time22. Pretreatment of animals with plant extract prevented th CCl4-induced
prolongation of pentobarbital-sleeping time suggestive of its protective effect against CCl4-induced
damage to hepatocytes including MDME. The possible mechanism of the protective effect of artemisia
scoparia would be rather speculative at this stage, however, it is clear from the results of sleeping time
study that the protective effect is not mediated through inhibition of hepatic MDME. We have recently
shown that the crude extract of artemisia scoparia exhibits Ca++ channel blocking activity in isolated
tissue experiments23. Calcium content in the liver cells are increased during the process of
experimental hepatic damage19,24 and calcium channel blocking drugs, i.e., nifedipine, diltiazem and
verapamil were found to inhibit the development of hepatic damage, induced by different hepatotoxins
including acetaminophen25 and CCl419. Similarly, hepatoprotective activity of the plant extract,
against acetaminophen reported previously6 and ccl4-induced liver damage reported in this study may
be attributed to its Ca++ channel blocking activity. Moreover, hepatoprotective action of the plant
extract may also be due to the occurrence of different types of plant constituents. It is interesting that
pure compounds such as rutin and other flavonoids from artemisia scoparia26 have already been
reported to have antioxidant, free radical scavenger and Ca++ channel blocking-like (non-specific
smooth muscle relaxant) activity in isolated tissue preparations27,28, though their hepatoprotective
activity was not studied. The plant extract afforded hepatoprotectivity both against acetaminopher6 and
CCl4 (this study) at the dose of 150 mg/kg, whereas higher dose (500 mg/kg) was required for this
activity in case of other plants tested in our laboratory such as, cyperus scariosus20, artemisia
absinthium29 and cichorium intybus30. The effectiveness of the crude extract of artemisia scoparia at a
dose, distinctly lower than that used for other plants may be due to the fact that this plant contains
multiple constituents which may have cumulative beneficial effect in liver injury. In conclusion, this
study provides the scientific basis for its traditional use in liver damage and further studies on the
constituents of this plant is in progress to explore its possible mode of hepatoprotective action.
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